Cargando…
NTG-101: A Novel Molecular Therapy that Halts the Progression of Degenerative Disc Disease
The tremendous cost, pain and disability associated with degenerative disc disease (DDD) makes the development of a biological agent that can mitigate the course of DDD, a critical unmet need. We have identified and reported that a single injection of a combination of recombinant human (rh) Transfor...
Autores principales: | Matta, Ajay, Karim, Muhammad Zia, Gerami, Hoda, Jun, Peter, Funabashi, Martha, Kawchuk, Greg, Goldstein, Alyssa, Foltz, Warren, Sussman, Marshall, Eek, Bjorn C., Erwin, W. Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6235869/ https://www.ncbi.nlm.nih.gov/pubmed/30429487 http://dx.doi.org/10.1038/s41598-018-35011-4 |
Ejemplares similares
-
A comparative study of mesenchymal stem cell transplantation and NTG-101 molecular therapy to treat degenerative disc disease
por: Matta, Ajay, et al.
Publicado: (2021) -
A Single Injection of NTG-101 Reduces the Expression of Pain-Related Neurotrophins in a Canine Model of Degenerative Disc Disease
por: Matta, Ajay, et al.
Publicado: (2022) -
The biological basis of degenerative disc disease: proteomic and biomechanical analysis of the canine intervertebral disc
por: Erwin, William Mark, et al.
Publicado: (2015) -
Injectable Biologics for the Treatment of Degenerative Disc Disease
por: Matta, Ajay, et al.
Publicado: (2020) -
Molecular Therapy for Degenerative Disc Disease: Clues from Secretome Analysis of the Notochordal Cell-Rich Nucleus Pulposus
por: Matta, Ajay, et al.
Publicado: (2017)